Advanced Adrenocortical Carcinoma (ACC): a Review with Focus on Second-Line Therapies
出版年份 2020 全文链接
标题
Advanced Adrenocortical Carcinoma (ACC): a Review with Focus on Second-Line Therapies
作者
关键词
-
出版物
Hormones & Cancer
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-04-17
DOI
10.1007/s12672-020-00385-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Objective response and prolonged disease control of advanced adrenocortical carcinoma with cabozantinib
- (2020) Matthias Kroiss et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma
- (2019) Chiara Fiorentini et al. Journal of Oncology
- Metastatic Adrenocortical Carcinoma: a Single Institutional Experience
- (2019) Dwight H. Owen et al. Hormones & Cancer
- PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma
- (2019) Emilien Billon et al. OncoImmunology
- Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
- (2019) Mouhammed Amir Habra et al. Journal for ImmunoTherapy of Cancer
- 901OEV-103: Initial results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma
- (2019) C J Hoimes et al. ANNALS OF ONCOLOGY
- Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors
- (2019) Salvatore Grisanti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- PD-1 Blockade in Advanced Adrenocortical Carcinoma
- (2019) Nitya Raj et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity and safety of temozolomide in advanced adrenocortical carcinoma patients
- (2019) Deborah Cosentini et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells
- (2018) Elaine Silveira et al. Cancer Cell International
- Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma
- (2018) Felix Megerle et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
- (2018) Martin Fassnacht et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry
- (2018) Matthias Kroiss et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Advanced Adrenocortical Carcinoma – What to do when First-Line Therapy Fails?
- (2018) Felix Megerle et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden
- (2018) Jose Mauricio Mota et al. MEDICINE
- Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
- (2018) Christophe Le Tourneau et al. Journal for ImmunoTherapy of Cancer
- Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors
- (2017) Judith E K Henning et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
- (2016) Siyuan Zheng et al. CANCER CELL
- Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene
- (2016) S. G. Creemers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide
- (2016) Matthias Kroiss et al. Hormones & Cancer
- Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
- (2015) Martin Fassnacht et al. LANCET ONCOLOGY
- Wnt addiction of genetically defined cancers reversed by PORCN inhibition
- (2015) B Madan et al. ONCOGENE
- Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
- (2015) Phuong N. Le et al. PHARMACOLOGY & THERAPEUTICS
- Safely targeting cancer stem cells via selective catenin coactivator antagonism
- (2014) Heinz-Josef Lenz et al. CANCER SCIENCE
- The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer
- (2014) Ciara O'Sullivan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin receptor expression in adrenocortical tumors and effect of a new somatostatin analog SOM230 on hormone secretion in vitro and in ex vivo adrenal cells
- (2014) B. Mariniello et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Integrated genomic characterization of adrenocortical carcinoma
- (2014) Guillaume Assié et al. NATURE GENETICS
- The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial
- (2014) Antonio M. Lerario et al. Hormones & Cancer
- Adrenocortical Carcinoma Is a Lynch Syndrome–Associated Cancer
- (2013) Victoria M. Raymond et al. JOURNAL OF CLINICAL ONCOLOGY
- ACAT-selective and Nonselective DGAT1 Inhibition
- (2013) Jan Eike Floettmann et al. TOXICOLOGIC PATHOLOGY
- Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) A. Berruti et al. ANNALS OF ONCOLOGY
- Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
- (2012) Matthias Kroiss et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Combination Chemotherapy in Advanced Adrenocortical Carcinoma
- (2012) Martin Fassnacht et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
- (2011) Matthias Kroiss et al. CLINICAL ENDOCRINOLOGY
- Mebendazole Monotherapy and Long-Term Disease Control in Metastatic Adrenocortical Carcinoma
- (2011) Irina Dobrosotskaya et al. Endocrine Practice
- Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma
- (2011) Alfredo Berruti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- [131I]Iodometomidate for Targeted Radionuclide Therapy of Advanced Adrenocortical Carcinoma
- (2011) Stefanie Hahner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adrenocortical carcinoma: a clinician's update
- (2011) Martin Fassnacht et al. Nature Reviews Endocrinology
- -Catenin Activation Is Associated with Specific Clinical and Pathologic Characteristics and a Poor Outcome in Adrenocortical Carcinoma
- (2010) S. Gaujoux et al. CLINICAL CANCER RESEARCH
- Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study
- (2010) Paola Sperone et al. ENDOCRINE-RELATED CANCER
- Adrenocortical development and cancer: focus on SF-1
- (2010) Enzo Lalli JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Transcatheter Arterial Chemoembolization for Liver Metastases in Patients with Adrenocortical Carcinoma
- (2010) Julien Cazejust et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
- (2010) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antitumoral effect of the bisphosphonate zoledronic acid against visceral metastases in an adrenocortical cancer patient
- (2009) P. Boudou-Rouquette et al. ANNALS OF ONCOLOGY
- Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
- (2009) Paul Haluska et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma
- (2009) Sebastian Wortmann et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Inhibition of Adrenocortical Carcinoma Cell Proliferation by Steroidogenic Factor-1 Inverse Agonists
- (2009) Mabrouka Doghman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Advanced Adrenocortical Carcinoma with Erlotinib plus Gemcitabine
- (2008) Marcus Quinkler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search